Resonant inc (RESN)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13
CASH FLOWS FROM OPERATING ACTIVITIES
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income (Loss) Attributable to Parent

-8,005

-7,846

-7,447

-7,498

-7,137

-6,873

-6,275

-5,952

-5,716

-8,312

-4,184

-4,263

-4,894

-5,206

-3,977

-2,988

-3,076

-2,471

-2,871

-2,145

-2,228

-2,172

-1,445

-2,167

-3,947

-6,127

-2,488

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

258

250

234

248

253

240

210

195

195

167

172

194

188

192

201

156

145

137

127

116

111

78

67

62

13

11

2

Benefit from income taxes

-

-

-

-

-

-

-

-

-

-

-16

2

-26

-23

0

0

0

-

-

-

-

-

-

-

-

-

-

Amortization of deferred finance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

1,695

709

629

721

Stock-based compensation

1,379

1,606

1,389

1,457

1,354

1,304

1,368

1,627

963

2,097

666

665

693

1,309

552

440

358

314

617

172

508

-

-

-

-

-

-

Non-cash loss on disposal of assets

0

-

0

0

-1

-

-8

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash investment income

0

-

-19

2

17

-

26

37

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrants and options issued for payment of services

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

715

Non-cash interest and investment income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2

5

5

6

-

-

-

-

-

-

Non-cash patent write-off

0

41

37

51

16

9

39

40

8

0

0

0

0

5

0

0

14

0

0

0

0

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

-

-

100

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Right-of-use asset amortization

147

146

144

241

55

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Bridge warrant expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

312

Fair value adjustments to warrant and derivative liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1

0

252

-2,267

-4,684

164

Changes in assets and liabilities:
Accounts receivable

-73

-1,928

1,957

0

-116

113

-69

-24

95

-15

-97

117

-11

3

16

0

0

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

156

112

-102

-45

45

-33

-152

26

-80

264

73

-24

63

-10

113

-109

14

22

-105

115

0

28

-4

-57

-45

-54

32

Other assets

0

0

0

0

-1

0

0

50

0

0

0

-11

14

1

0

0

0

-

-

-

-

-

-

-

-

4

7

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-36

91

208

-53

53

-

-

-

0

-

-

-

-

-

-

Deferred taxes

-

-

-

-

-

-

-

-

-

-

-

-

7

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable

51

-31

156

55

69

19

26

-341

403

-256

361

-371

123

-218

92

-116

298

135

115

-140

185

77

-494

449

99

-43

-250

Accrued expenses

-256

109

60

30

11

16

78

-81

-79

77

16

27

43

-157

73

50

0

10

2

27

-125

71

50

-82

-57

18

86

Accrued salaries and payroll related expenses

-308

624

-78

341

-696

771

-51

140

-526

49

-1

168

-8

931

13

132

-96

-338

308

118

-9

160

56

23

62

-

-

Customer deposits

-

-

-

-

-

-

-

-

130

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-262

-378

1,922

-17

-67

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities

-148

-

-

-

-11

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-262

-378

1,922

-17

-67

82

-50

96

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent

-

-

-

-

-

-

-

-

-

-

0

12

0

-

9

8

9

-

9

9

9

-

-

-

-

-

-

Net cash used in operating activities

-7,227

-3,806

-5,556

-5,247

-6,097

-4,553

-4,450

-4,391

-4,737

-3,826

-2,945

-3,713

-3,990

-

-

-

-

-

-

-

-

-

-

-

-

-

-

CASH FLOWS FROM INVESTING ACTIVITIES
Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,977

-2,279

-2,327

-2,246

-1,611

-1,981

-1,573

-1,365

-1,625

-814

-809

-760

-1,103

CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property and equipment

200

91

138

274

303

420

313

33

519

321

125

136

233

25

139

145

91

38

209

104

64

430

47

390

150

189

41

Expenditures for patents and domain names

132

118

111

90

105

62

65

49

43

88

51

68

125

1

71

71

34

76

101

44

121

58

17

18

47

39

50

Purchase of restricted cash investment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

100

-

-

-

-

-

-

Redemption of investments held-to-maturity

0

-

4,464

5,472

19,359

-

10,617

28,973

0

-

0

0

4,747

-

2,249

0

3,006

-

3,000

2,000

8,000

-

-

-

-

-

-

Purchase of investments held-to-maturity

0

0

0

3,476

8,956

7,889

0

23,426

24,985

0

0

0

0

-

-

-

-

0

0

1,000

8,989

-

-

-

-

-

-

Net cash provided by (used in) investing activities

-332

-209

4,215

1,632

9,995

-8,371

10,255

5,465

-25,547

-402

-176

-204

4,389

-

-

-

-

-

-

-

-

-

-

-

-

-

-

CASH FLOWS FROM FINANCING ACTIVITIES
Net cash provided by (used in) investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-6,413

-4,465

2,881

1,886

2,690

852

-1,274

-488

-8,044

-408

-197

-229

-91

CASH FLOWS FROM FINANCING ACTIVITIES
Net proceeds from the sale of common stock from underwritten public offering

26,460

-

-

-

0

-

-

-

-

925

7,557

-3

7,471

0

0

5,177

0

-

-

-

-

-

-

-

-

-

-

Net proceeds from the sale of common stock from underwritten public offering

-

-

-

-

-

-

0

2,809

18,381

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred IPO cost

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

2,170

218

-

-

Proceeds from exercise of warrants

0

0

0

987

400

0

0

217

43

9,272

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payment of note payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

100

Payment of bridge loan

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

200

Proceeds from issuance of convertible note

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

7,000

Deferred financing cost

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

1,154

Net cash provided by financing activities

26,460

-21

9,940

987

400

-152

0

3,040

18,424

10,221

7,557

51

7,471

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payment of withholding tax on net exercise of stock-based awards

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

14

31

-

-

-

-

-

-

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10,621

5,177

0

0

0

-14

-31

-29

0

16,461

-218

-74

5,545

Effects of currency translation on cash, cash equivalents and restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-6

0

0

0

-

-

-

-

-

-

-

-

-

-

Effects of exchange rates on cash, cash equivalents and restricted cash

0

0

-1

2

-1

0

-6

1

3

-

6

-3

3

-

-

-

-

-

-

-

-

-

-

-

-

-

-

NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH

18,901

-4,036

8,598

-2,626

4,297

-13,076

5,799

4,115

-11,857

5,994

4,442

-3,869

7,873

-

-

-

-

-

-

-

-

-

-

-

-

-

-

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

-

-

-

-

-

-

Taxes Paid

1

0

0

0

1

0

0

0

3

0

0

0

1

0

0

0

1

0

0

1

0

0

0

0

1

-

-

SUPPLEMENTAL DISCLOSURE OF NON-CASH ACTIVITIES
Deferred financing costs included in accounts payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

Issuance of common stock in settlement of liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

110

0

-

0

0

0

-

-

-

-

-

-

Restricted stock units issued in settlement of liability

280

-349

35

314

0

-998

277

291

436

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Issuance of subordinated note in exchange for Class C units

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

2,400

Charge to equity for difference in fair value of subordinate note

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,133

Debt discount in conjunction with subordinated note

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0

266

Debt discount in conjunction with senior note

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

329

Debt discount in conjunction with senior note-derivative

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

2,005

Common stock issued in settlement of accrued salaries and payroll related expenses

-

-

-

-

-

-

-

-

-

-153

0

153

119

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock options issued in settlement of liability

-

-

-

-

-

-

-

-

-

-248

248

0

332

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaids included in accounts payable

-

-

-

-

-

-

-

-

-

-

-

-

43

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Property and equipment included in accounts payable

142

169

20

-107

124

-29

102

14

8

215

0

27

3

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock options issued in settlement of liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

Prepaids included in accounts payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

Property and equipment included in accrued liabilities

46

143

-41

-35

92

23

282

0

0

-

-

-

-

0

0

0

0

-

-

-

-

-

-

-

-

-

-

Patents included in accounts payable

84

13

54

-7

23

7

-10

7

35

-24

10

-13

36

-

0

0

0

-

-

-

-

-

-

-

-

-

-

Patents included in accrued liabilities

0

-

-

-

19

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
NET INCREASE IN CASH AND CASH EQUIVALENTS

-

-

-

-

-

-

-

-

-

-

-

-

-

2,365

1,231

-1,567

554

-360

1,079

-1,143

-2,878

-1,882

-9,669

15,239

-1,224

-1,063

4,350